These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29346085)

  • 1. Performance of the BioPlex 2200 HIV Ag-Ab assay for identifying acute HIV infection.
    Eshleman SH; Piwowar-Manning E; Sivay MV; Debevec B; Veater S; McKinstry L; Bekker LG; Mannheimer S; Grant RM; Chesney MA; Coates TJ; Koblin BA; Fogel JM
    J Clin Virol; 2018; 99-100():67-70. PubMed ID: 29346085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa.
    Piwowar-Manning E; Fogel JM; Richardson P; Wolf S; Clarke W; Marzinke MA; Fiamma A; Donnell D; Kulich M; Mbwambo JK; Richter L; Gray G; Sweat M; Coates TJ; Eshleman SH
    J Clin Virol; 2015 Jan; 62():75-9. PubMed ID: 25542477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of three FDA-approved HIV Ag/Ab combination tests using a genetically diverse HIV panel and diagnostic specimens.
    Qiu X; Sokoll L; Yip P; Elliott DJ; Dua R; Mohr P; Wang XY; Spencer M; Swanson P; Dawson GJ; Hackett J
    J Clin Virol; 2017 Jul; 92():62-68. PubMed ID: 28535437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance comparison of the 4th generation Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA on the EVOLIS™ automated system versus Abbott ARCHITECT HIV Ag/Ab Combo, Ortho Anti-HIV 1+2 EIA on Vitros ECi and Siemens HIV-1/O/2 enhanced on Advia Centaur.
    Mitchell EO; Stewart G; Bajzik O; Ferret M; Bentsen C; Shriver MK
    J Clin Virol; 2013 Dec; 58 Suppl 1():e79-84. PubMed ID: 24342482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma.
    Bentsen C; McLaughlin L; Mitchell E; Ferrera C; Liska S; Myers R; Peel S; Swenson P; Gadelle S; Shriver MK
    J Clin Virol; 2011 Dec; 52 Suppl 1():S57-61. PubMed ID: 21995929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Seroreactivity in Individuals Initiating Antiretroviral Therapy during Acute HIV Infection.
    Manak MM; Jagodzinski LL; Shutt A; Malia JA; Leos M; Ouellette J; Akapirat S; Colby DL; Phanuphak N; Eller LA; Robb ML; de Souza M; Ananworanich J; Peel SA;
    J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31217270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARCHITECT® HIV Ag/Ab Combo assay: correlation of HIV-1 p24 antigen sensitivity and RNA viral load using genetically diverse virus isolates.
    Brennan CA; Yamaguchi J; Vallari A; Swanson P; Hackett JR
    J Clin Virol; 2013 Jun; 57(2):169-72. PubMed ID: 23485348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection.
    Ramos EM; Harb S; Dragavon J; Swenson P; Stekler JD; Coombs RW
    J Clin Virol; 2013 Dec; 58 Suppl 1(0 1):e38-43. PubMed ID: 24029686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fourth generation Alere
    Livant E; Heaps A; Kelly C; Maharaj R; Samsunder N; Nhlangulela L; Karugaba P; Panchia R; Marrazzo J; Chirenje ZM; Parikh UM;
    J Clin Virol; 2017 Sep; 94():15-21. PubMed ID: 28710996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
    Kirkpatrick AR; Patel EU; Celum CL; Moore RD; Blankson JN; Mehta SH; Kirk GD; Margolick JB; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):756-62. PubMed ID: 26988426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterophilic interference in specimens yielding false-reactive results on the Abbott 4th generation ARCHITECT HIV Ag/Ab Combo assay.
    Lavoie S; Caswell D; Gill MJ; Kadkhoda K; Charlton CL; Levett PN; Hatchette T; Garceau R; Maregmen J; Mazzulli T; Needle R; Kadivar K; Kim J
    J Clin Virol; 2018 Jul; 104():23-28. PubMed ID: 29704735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Detection Limits of Fourth- and Fifth-Generation Combination HIV Antigen-Antibody, p24 Antigen, and Viral Load Assays on Diverse HIV Isolates.
    Stone M; Bainbridge J; Sanchez AM; Keating SM; Pappas A; Rountree W; Todd C; Bakkour S; Manak M; Peel SA; Coombs RW; Ramos EM; Shriver MK; Contestable P; Nair SV; Wilson DH; Stengelin M; Murphy G; Hewlett I; Denny TN; Busch MP
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29793968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of fourth-generation ARCHITECT HIV Ag/Ab Combo assay and utility of signal-to-cutoff ratio to predict false-positive HIV tests in pregnancy.
    Adhikari EH; Macias D; Gaffney D; White S; Rogers VL; McIntire DD; Roberts SW
    Am J Obstet Gynecol; 2018 Oct; 219(4):408.e1-408.e9. PubMed ID: 29913173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance evaluation of the FDA-approved Determine™ HIV-1/2 Ag/Ab Combo assay using plasma and whole blood specimens.
    Masciotra S; Luo W; Westheimer E; Cohen SE; Gay CL; Hall L; Pan Y; Peters PJ; Owen SM
    J Clin Virol; 2017 Jun; 91():95-100. PubMed ID: 28372891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay.
    Chavez P; Wesolowski L; Patel P; Delaney K; Owen SM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S51-5. PubMed ID: 21983253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of dried blood spot protocols with the Bio-Rad GS HIV Combo Ag/Ab EIA and Geenius™ HIV 1/2 Supplemental Assay.
    Luo W; Davis G; Li L; Shriver MK; Mei J; Styer LM; Parker MM; Smith A; Paz-Bailey G; Ethridge S; Wesolowski L; Owen SM; Masciotra S
    J Clin Virol; 2017 Jun; 91():84-89. PubMed ID: 28366544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of early HIV infections using the fourth generation Abbott ARCHITECT HIV Ag/Ab Combo chemiluminescent microparticle immunoassay (CIA) in San Diego County.
    Manlutac AL; Giesick JS; McVay PA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e44-7. PubMed ID: 24342477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of serological and molecular tests within acute HIV infection.
    Fransen K; de Baetselier I; Rammutla E; Ahmed K; Owino F; Agingu W; Venter G; Deese J; Van Damme L; Crucitti T;
    J Clin Virol; 2017 Aug; 93():81-84. PubMed ID: 28351688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost savings associated with testing of antibodies, antigens, and nucleic acids for diagnosis of acute HIV infection.
    Karris MY; Anderson CM; Morris SR; Smith DM; Little SJ
    J Clin Microbiol; 2012 Jun; 50(6):1874-8. PubMed ID: 22442319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the Abbott Architect HIV antigen/antibody assay in a low incidence population.
    Dubravac T; Gahan TF; Pentella MA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e76-8. PubMed ID: 24342481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.